Lawlor Sally Bridget 4
4 · Quoin Pharmaceuticals, Ltd. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Lawlor Sally Bridget
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2025-12-01+10,330→ 10,330 totalExercise: $19.36Exp: 2035-12-01→ ADS (10,330 underlying)
Footnotes (3)
- [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.
- [F2]The option grant was approved by the Compensation Committee of the Board of Directors of the Issuer on December 1, 2025.
- [F3]The option vests in four annual installments with 20% vesting on each of December 1, 2026, 2027 and 2028 and 40% vesting on December 1, 2029.